CSPIA
TWST icon

Cary Street Partners Investment Advisory’s Twist Bioscience TWST Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-154
Closed -$3.12K – 1720
2023
Q3 		$3.12K Hold
154
– – ﹤0.01% 1591
2023
Q2 		$3.15K Hold
154
– – ﹤0.01% 1517
2023
Q1 		$2.32K Hold
154
– – ﹤0.01% 1477
2022
Q4 		$3.67K Buy
+154
New +$4.46K ﹤0.01% 1400

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cary Street Partners Investment Advisory's TWST Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Twist Bioscience (TWST) in Q4 2023, closing a stake of 154 shares — an estimated $3.12K sold.

Cary Street Partners Investment Advisory first reported a position in TWST in Q4 2022 and held it in 4 quarters. The position peaked at $3.67K in Q4 2022. 219 funds tracked by Wall St. Rank hold TWST as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Twist Bioscience position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 154 Twist Bioscience shares in Q4 2023, an estimated $3.12K.
  • Cary Street Partners Investment Advisory first reported a position in Twist Bioscience in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Twist Bioscience position peaked at $3.67K in Q4 2022.
  • 219 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.